Julie Hambleton, Director at SpringWorks Therapeutics, Inc. (SWTX), sold 7,594 shares at $39.41 ($302K) on 2024-06-03, disclosed to the SEC on 2024-06-05.
Scheduled sale ($302k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.41 | 2,946 | $116K | 38.4% |
| 2 | $39.41 | 2,946 | $116K | 38.4% |
| 3 | $40.57 | 751 | $30K | 10.1% |
| 4 | $41.49 | 931 | $39K | 12.8% |
| 5 | $42.09 | 20 | $842 | 0.3% |
| Total | $39.79 avg | 7,594 |
| $302K |
| 100% |
| Filing → |
| SWTX | SELL | 2023-07-21 | $142K | — | Filing → |
| SWTX | SELL | 2023-06-22 | $129K | — | Filing → |
| SWTX | SELL | 2023-03-16 | $35K | — | Filing → |